Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 2
3(33.3%)
N/A
2(22.2%)
Phase 1
2(22.2%)
Early Phase 1
1(11.1%)
Phase 3
1(11.1%)
9Total
Phase 2(3)
N/A(2)
Phase 1(2)
Early Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT07032558Phase 1Recruiting

Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions

Role: collaborator

NCT07060209Phase 1Recruiting

Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults

Role: collaborator

NCT06657495Phase 2Recruiting

To Evaluate the Safety and Efficacy of TD0015 Pilulae in Patients with Knee Osteoarthritis

Role: collaborator

NCT04373941Phase 2Unknown

Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia

Role: collaborator

NCT03845348Phase 3Unknown

To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases

Role: collaborator

NCT05044650Not ApplicableUnknown

Efficacy of KOVIR Capsule in the Combination Regimen With Background Treatment in COVID-19 Patients

Role: collaborator

NCT05042141Not ApplicableCompleted

Safety and Efficacy of KOVIR in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR)

Role: collaborator

NCT03395028Early Phase 1Completed

GCSF Adjunct Therapy for Biliary Atresia

Role: collaborator

NCT03845959Phase 2Completed

A Trial of TD0019 in Treatment of Cervical Scapulohumeral Syndrome

Role: collaborator

All 9 trials loaded